OMENN GILBERT S
Insider CIK 1184227 · GALT Director · ESPR Director · ANGN Director · NONE Director · AMST Director · AMGN Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AMST Amesite Inc. | A Award deriv | 2026-09-30 | 2026-10-02 | 12,121 | — | $0 | 95,927 | SEC↗ |
| AMST Amesite Inc. | A Award deriv | 2026-06-30 | 2026-07-01 | 9,023 | — | $0 | 83,806 | SEC↗ |
| AMST Amesite Inc. | A Award deriv | 2026-03-31 | 2026-04-01 | 6,522 | — | $0 | 74,783 | SEC↗ |
| AMST Amesite Inc. | M Exercise deriv | 2026-03-07 | 2026-03-10 | 41,322 | — | $0 | 0 | SEC↗ |
| AMST Amesite Inc. | M Exercise | 2026-03-07 | 2026-03-10 | 41,322 | — | $0 | 143,699 | SEC↗ |
| AMST Amesite Inc. | A Award deriv | 2026-02-06 | 2026-02-10 | 49,751 | — | $0 | 49,751 | SEC↗ |
| GALT GALECTIN THERAPEUTICS INC | A Award deriv | 2026-01-16 | 2026-01-21 | 60,000 | — | $0 | 60,000 | SEC↗ |
| AMST Amesite Inc. | A Award deriv | 2025-12-31 | 2026-01-05 | 6,349 | — | $0 | 68,261 | SEC↗ |
| AMST Amesite Inc. | A Award deriv | 2025-09-30 | 2025-10-02 | 3,934 | — | $0 | 61,912 | SEC↗ |
| AMST Amesite Inc. | A Award deriv | 2025-06-30 | 2025-07-02 | 4,461 | — | $0 | 57,978 | SEC↗ |
| AMST Amesite Inc. | A Award deriv | 2025-03-31 | 2025-04-02 | 4,959 | — | $0 | 53,517 | SEC↗ |
| AMST Amesite Inc. | A Award deriv | 2025-03-07 | 2025-03-11 | 41,322 | — | $0 | 41,322 | SEC↗ |
| AMST Amesite Inc. | A Award | 2025-03-07 | 2025-03-11 | 41,322 | — | $0 | 102,377 | SEC↗ |
| GALT GALECTIN THERAPEUTICS INC | A Award deriv | 2025-01-23 | 2025-01-27 | 60,000 | — | $0 | 60,000 | SEC↗ |
| GALT GALECTIN THERAPEUTICS INC | A Award deriv | 2025-01-23 | 2025-01-27 | 60,000 | — | $0 | 60,000 | SEC↗ |
| AMST Amesite Inc. | M Exercise deriv | 2025-01-16 | 2025-01-16 | 36,630 | — | $0 | 0 | SEC↗ |
| AMST Amesite Inc. | M Exercise | 2025-01-16 | 2025-01-16 | 36,630 | — | $0 | 46,435 | SEC↗ |
| AMST Amesite Inc. | P Buy | 2025-01-07 | 2025-01-08 | 3,333 | $3.00 | $10.0K | 9,805 | SEC↗ |
| AMST Amesite Inc. | A Award deriv | 2024-12-31 | 2025-01-03 | 2,526 | — | $0 | 48,558 | SEC↗ |
| AMST Amesite Inc. | A Award deriv | 2024-09-30 | 2024-10-02 | 4,898 | — | $0 | 46,032 | SEC↗ |
| AMST Amesite Inc. | A Award deriv | 2024-06-28 | 2024-07-02 | 4,000 | — | $0 | 41,134 | SEC↗ |
| AMST Amesite Inc. | A Award deriv | 2024-03-28 | 2024-04-01 | 5,381 | — | $0 | 37,134 | SEC↗ |
| GALT GALECTIN THERAPEUTICS INC | A Award deriv | 2024-01-24 | 2024-02-07 | 50,000 | — | $0 | 50,000 | SEC↗ |
| AMST Amesite Inc. | A Award deriv | 2024-01-16 | 2024-01-18 | 36,630 | — | $0 | 36,630 | SEC↗ |
| AMST Amesite Inc. | A Award deriv | 2023-12-29 | 2024-01-03 | 5,333 | — | $0 | 31,753 | SEC↗ |
| AMST Amesite Inc. | A Award deriv | 2023-09-29 | 2023-10-03 | 4,706 | — | $0 | 26,420 | SEC↗ |
| AMST Amesite Inc. | A Award deriv | 2023-06-30 | 2023-07-05 | 3,324 | — | $0 | 21,714 | SEC↗ |
| AMST Amesite Inc. | M Exercise deriv | 2023-03-31 | 2025-03-11 | 14,620 | — | $0 | 0 | SEC↗ |
| AMST Amesite Inc. | M Exercise | 2023-03-31 | 2025-03-11 | 14,620 | — | $0 | 61,055 | SEC↗ |
| AMST Amesite Inc. | A Award deriv | 2023-03-31 | 2023-04-04 | 4,598 | — | $0 | 18,390 | SEC↗ |
| GALT GALECTIN THERAPEUTICS INC | A Award deriv | 2023-01-26 | 2023-01-30 | 40,000 | — | $0 | 40,000 | SEC↗ |
| AMST Amesite Inc. | A Award deriv | 2022-12-30 | 2023-01-05 | 68,571 | — | $0 | 165,504 | SEC↗ |
| AMST Amesite Inc. | A Award deriv | 2022-09-30 | 2022-10-03 | 49,793 | — | $0 | 96,933 | SEC↗ |
| AMST Amesite Inc. | A Award deriv | 2022-06-30 | 2022-07-05 | 26,087 | — | $0 | 47,140 | SEC↗ |
| ANGN Angion Biomedica Corp. | A Award deriv | 2022-06-09 | 2022-06-13 | 15,000 | — | $0 | 15,000 | SEC↗ |
| AMST Amesite Inc. | A Award deriv | 2022-03-31 | 2022-07-05 | 21,053 | — | $0 | 21,053 | SEC↗ |
| AMST Amesite Inc. | A Award deriv | 2022-03-31 | 2022-04-04 | 175,439 | — | $0 | 175,439 | SEC↗ |
| AMST Amesite Inc. | A Award deriv | 2022-03-31 | 2022-04-04 | 84,211 | — | $0 | 84,211 | SEC↗ |
| GALT GALECTIN THERAPEUTICS INC | A Award deriv | 2022-01-24 | 2022-01-25 | 40,000 | — | $0 | 40,000 | SEC↗ |
| AMST Amesite Inc. | P Buy | 2021-12-14 | 2021-12-15 | 8,000 | $1.17 | $9.4K | 77,666 | SEC↗ |
| AMST Amesite Inc. | P Buy | 2021-12-13 | 2021-12-15 | 8,000 | $1.18 | $9.4K | 69,666 | SEC↗ |
| AMST Amesite Inc. | A Award deriv | 2021-09-28 | 2022-04-04 | 9,184 | — | $0 | 9,184 | SEC↗ |
| GALT GALECTIN THERAPEUTICS INC | A Award deriv | 2021-03-25 | 2021-03-29 | 70,000 | — | $0 | 70,000 | SEC↗ |
| GALT GALECTIN THERAPEUTICS INC | A Award deriv | 2021-03-25 | 2021-03-29 | 40,000 | — | $0 | 40,000 | SEC↗ |
| ANGN Angion Biomedica Corp. | A Award deriv | 2021-03-08 | 2021-03-10 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ANGN Angion Biomedica Corp. | C Conversion deriv | 2021-02-09 | 2021-02-11 | 0 | — | $0 | 0 | SEC↗ |
| ANGN Angion Biomedica Corp. | C Conversion deriv | 2021-02-09 | 2021-02-11 | 0 | — | $0 | 0 | SEC↗ |
| ANGN Angion Biomedica Corp. | C Conversion deriv | 2021-02-09 | 2021-02-11 | 0 | — | $0 | 0 | SEC↗ |
| ANGN Angion Biomedica Corp. | C Conversion | 2021-02-09 | 2021-02-11 | 23,391 | $11.57 | $270.6K | 65,543 | SEC↗ |
| ANGN Angion Biomedica Corp. | C Conversion | 2021-02-09 | 2021-02-11 | 23,483 | $11.57 | $271.7K | 42,152 | SEC↗ |
| ANGN Angion Biomedica Corp. | C Conversion | 2021-02-09 | 2021-02-11 | 14,783 | $11.57 | $171.0K | 80,326 | SEC↗ |
| AMST Amesite Inc. | P Buy | 2020-09-29 | 2020-09-29 | 20,000 | $5.00 | $100.0K | 61,666 | SEC↗ |
| NONE Amesite Inc. | A Award deriv | 2020-03-31 | 2020-04-06 | 10,000 | — | $0 | 10,000 | SEC↗ |
| NONE Amesite Inc. | A Award deriv | 2020-03-31 | 2020-04-06 | 50,000 | — | $0 | 50,000 | SEC↗ |
| GALT GALECTIN THERAPEUTICS INC | A Award deriv | 2020-01-09 | 2020-01-13 | 40,000 | — | $0 | 40,000 | SEC↗ |
| GALT GALECTIN THERAPEUTICS INC | P Buy deriv | 2019-05-31 | 2019-06-03 | 61,929 | — | $0 | 61,929 | SEC↗ |
| GALT GALECTIN THERAPEUTICS INC | P Buy | 2019-05-31 | 2019-06-03 | 18,578 | $4.28 | $79.5K | 66,769 | SEC↗ |
| GALT GALECTIN THERAPEUTICS INC | A Award deriv | 2019-01-16 | 2019-01-18 | 35,000 | — | $0 | 35,000 | SEC↗ |
| GALT GALECTIN THERAPEUTICS INC | S Sale | 2018-09-10 | 2018-09-11 | 8,370 | $6.00 | $50.2K | 48,191 | SEC↗ |
| GALT GALECTIN THERAPEUTICS INC | S Sale | 2018-09-07 | 2018-09-11 | 11,000 | $6.03 | $66.3K | 56,561 | SEC↗ |
| GALT GALECTIN THERAPEUTICS INC | A Award deriv | 2017-12-14 | 2017-12-18 | 62,250 | — | $0 | 62,250 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award deriv | 2017-04-17 | 2017-04-19 | 14,000 | — | $0 | 14,000 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | P Buy | 2017-03-21 | 2017-03-22 | 1,000 | $42.26 | $42.3K | 1,000 | SEC↗ |
| GALT GALECTIN THERAPEUTICS INC | A Award deriv | 2016-12-15 | 2016-12-19 | 41,500 | — | $0 | 41,500 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award deriv | 2016-06-09 | 2016-06-10 | 8,000 | — | $0 | 8,000 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | P Buy | 2016-03-01 | 2016-03-02 | 5,000 | $15.28 | $76.4K | 10,000 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award deriv | 2015-05-14 | 2015-05-18 | 8,000 | — | $0 | 8,000 | SEC↗ |
| GALT GALECTIN THERAPEUTICS INC | D To issuer deriv | 2015-04-08 | 2015-07-08 | 28,323 | — | $0 | 0 | SEC↗ |
| GALT GALECTIN THERAPEUTICS INC | A Award | 2015-04-08 | 2015-07-08 | 25,934 | — | $0 | 67,561 | SEC↗ |
| GALT GALECTIN THERAPEUTICS INC | A Award | 2015-04-07 | 2015-07-08 | 1,506 | — | $0 | 41,627 | SEC↗ |
| GALT GALECTIN THERAPEUTICS INC | A Award | 2015-03-12 | 2015-07-08 | 11,112 | — | $0 | 40,121 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | P Buy | 2014-10-21 | 2014-10-21 | 5,000 | $20.00 | $100.0K | 5,000 | SEC↗ |
| GALT GALECTIN THERAPEUTICS INC | A Award deriv | 2014-09-23 | 2014-09-24 | 28,323 | — | $0 | 28,323 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award deriv | 2014-08-07 | 2014-08-08 | 20,000 | — | $0 | 20,000 | SEC↗ |
| AMGN AMGEN INC | A Award | 2014-04-25 | 2014-04-29 | 1,795 | — | $0 | 180,547 | SEC↗ |
| AMGN AMGEN INC | A Award | 2013-04-26 | 2013-04-30 | 1,845 | — | $0 | 178,669 | SEC↗ |
| AMGN AMGEN INC | M Exercise deriv | 2012-11-26 | 2012-11-26 | 5,000 | — | $0 | 0 | SEC↗ |
| AMGN AMGEN INC | M Exercise deriv | 2012-11-26 | 2012-11-26 | 16,000 | — | $0 | 0 | SEC↗ |
| AMGN AMGEN INC | M Exercise deriv | 2012-11-26 | 2012-11-26 | 5,000 | — | $0 | 0 | SEC↗ |
| AMGN AMGEN INC | M Exercise | 2012-11-26 | 2012-11-26 | 16,000 | $50.78 | $812.5K | 192,783 | SEC↗ |
| AMGN AMGEN INC | M Exercise | 2012-11-26 | 2012-11-26 | 5,000 | $74.89 | $374.4K | 197,783 | SEC↗ |
| AMGN AMGEN INC | M Exercise | 2012-11-26 | 2012-11-26 | 5,000 | $62.55 | $312.8K | 202,783 | SEC↗ |
| AMGN AMGEN INC | S Sale | 2012-11-26 | 2012-11-26 | 26,000 | $87.11 | $2.26M | 176,783 | SEC↗ |
| AMGN AMGEN INC | G Gift | 2012-10-25 | 2012-10-26 | 8,572 | — | $0 | 176,783 | SEC↗ |
| AMGN AMGEN INC | A Award deriv | 2012-04-27 | 2012-05-01 | 5,000 | $71.64 | $358.2K | 5,000 | SEC↗ |
| AMGN AMGEN INC | A Award | 2012-04-27 | 2012-05-01 | 1,395 | — | $0 | 185,313 | SEC↗ |
| AMGN AMGEN INC | M Exercise deriv | 2012-02-29 | 2012-02-29 | 5,000 | — | $0 | 0 | SEC↗ |
| AMGN AMGEN INC | F Tax w/h | 2012-02-29 | 2012-02-29 | 4,301 | $68.15 | $293.1K | 183,852 | SEC↗ |
| AMGN AMGEN INC | M Exercise | 2012-02-29 | 2012-02-29 | 5,000 | $58.61 | $293.1K | 188,153 | SEC↗ |